Janssen Shows Commitment to Advancing the Science and Treatment of Blood Cancers and Related Conditions With More Than 80 ASH 2018 Data Presentations From Differentiated Oncology and Cardiovascular Portfolios
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Pharmaceuticals | Science